Stratos Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.9M | Buy |
147,259
+2,476
| +2% | +$290K | 0.68% | 38 |
|
|
2026
Q1 | $17.4M | Buy |
144,783
+9,502
| +7% | +$1.1M | 0.7% | 34 |
|
|
2025
Q4 | $14.2M | Buy |
135,281
+6,952
| +5% | +$653K | 0.57% | 44 |
|
|
2025
Q3 | $10.8M | Buy |
128,329
+8,090
| +7% | +$666K | 0.44% | 57 |
|
|
2025
Q2 | $9.52M | Buy |
120,239
+8,237
| +7% | +$655K | 0.44% | 54 |
|
|
2025
Q1 | $10.1M | Buy |
112,002
+66,737
| +147% | +$6.23M | 0.54% | 45 |
|
|
2024
Q4 | $4.5M | Sell |
45,265
-35,216
| -44% | -$3.63M | 0.27% | 71 |
|
|
2024
Q3 | $9.14M | Buy |
80,481
+25,362
| +46% | +$3.01M | 0.64% | 45 |
|
|
2024
Q2 | $6.82M | Buy |
55,119
+16,999
| +45% | +$2.19M | 0.57% | 50 |
|
|
2024
Q1 | $5.03M | Buy |
38,120
+19,126
| +101% | +$2.36M | 0.49% | 56 |
|
|
2023
Q4 | $2.07M | Buy |
18,994
+47
| +0.2% | +$4.88K | 0.25% | 81 |
|
|
2023
Q3 | $1.95M | Buy |
18,947
+1,100
| +6% | +$119K | 0.29% | 75 |
|
|
2023
Q2 | $2.06M | Buy |
17,847
+1,868
| +12% | +$212K | 0.32% | 70 |
|
|
2023
Q1 | $1.7M | Buy |
15,979
+9,509
| +147% | +$1.03M | 0.29% | 74 |
|
|
2022
Q4 | $718K | Sell |
6,470
-186
| -3% | -$19K | 0.13% | 102 |
|
|
2022
Q3 | $573K | Buy |
6,656
+2,939
| +79% | +$262K | 0.12% | 101 |
|
|
2022
Q2 | $339K | Buy |
3,717
+223
| +6% | +$19.8K | 0.06% | 124 |
|
|
2022
Q1 | $287K | Buy |
3,494
+191
| +6% | +$15.1K | 0.05% | 142 |
|
|
2021
Q4 | $253K | Sell |
3,303
-4,797
| -59% | -$382K | 0.04% | 169 |
|
|
2021
Q3 | $608K | Sell |
8,100
-34,153
| -81% | -$2.6M | 0.11% | 127 |
|
|
2021
Q2 | $3.29M | Sell |
42,253
-4,876
| -10% | -$363K | 0.9% | 36 |
|
|
2021
Q1 | $3.47M | Sell |
47,129
-2,373
| -5% | -$175K | 1.1% | 27 |
|
|
2020
Q4 | $3.86M | Buy |
49,502
+9,162
| +23% | +$701K | 1.22% | 26 |
|
|
2020
Q3 | $3.19M | Buy |
40,340
+5,398
| +15% | +$423K | 1.16% | 27 |
|
|
2020
Q2 | $2.58M | Buy |
34,942
+6,346
| +22% | +$478K | 1.09% | 28 |
|
|
2020
Q1 | $2.1M | Buy |
28,596
+12,500
| +78% | +$982K | 1.12% | 26 |
|
|
2019
Q4 | $1.4M | Buy |
16,096
+1,122
| +7% | +$92.2K | 0.65% | 41 |
|
|
2019
Q3 | $1.2M | Buy |
14,974
+1,457
| +11% | +$117K | 0.68% | 39 |
|
|
2019
Q2 | $1.08M | Buy |
13,517
+1,885
| +16% | +$144K | 0.68% | 39 |
|
|
2019
Q1 | $923K | Buy |
+11,632
| New | +$870K | 0.73% | 39 |
|
Other funds holding MRK
Stratos Investment Management's MRK Position: Q2 2026 in Review
Stratos Investment Management increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $290K and bringing the position to 147,259 shares worth $18.9M. The position accounts for 0.68% of the portfolio, ranked #38.
Stratos Investment Management first reported a position in MRK in Q1 2019 and has held it in 30 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Stratos Investment Management held 147,259 shares of Merck worth $18.9M as of Q2 2026.
- Stratos Investment Management bought 2,476 Merck shares in Q2 2026, an estimated $290K.
- Merck made up 0.68% of Stratos Investment Management's portfolio in Q2 2026, its #38 holding.
- Stratos Investment Management first reported a position in Merck in Q1 2019 and has held it in 30 quarters since.
- 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Stratos Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.